lentiviral vectors
lentiviral vectors
MilliporeSigma Boosts Gene Therapy with $600M Acquisition!
MilliporeSigma acquires Mirus Bio for $600 million, boosting viral vector manufacturing and supporting gene therapy advancements! 🚀🔬💡🤝
Revolutionizing Vector Production with Smart Tech!
Unlocking the future of vector production! 🌱 Experts recommend purpose-built tech and AI to enhance efficiency and scalability. 🔧🤖
Boosting Biopharma Confidence with Cutting-Edge Tools
🧪 Charles River Laboratories: Tools & services for efficient production & testing of cell, gene, & gene-modified therapy products. 🔬 Reference materials for assay development & validation. 🧬 Technology transfer & Flex Platform for cell therapy development. 💪 Accelerating new therapies with consistency & confidence.
Revolutionary Cell Manufacturing Lines for Gene Therapies: Cytiva’s Game-Changing Solution
📢 Cytiva introduces new cell manufacturing lines for viral vectors in gene therapies, aiming to standardize manufacturing and reduce costs. 💼💡🔬🚀
Game-changing Partnership: Naobios and Sumagen Unite to Tackle HIV Vaccine Challenge
🌍 Naobios and Sumagen join forces to develop an HIV vaccine, using cutting-edge bioprocess and viral vector technology. 🧬🔬
Revolutionary 10-Day Lentiviral Vector Breakthrough Boosts Gene Therapy Efficiency
🔍 Researchers have developed a method to optimize lentiviral vector production, allowing for high-titer LV harvest for more than 10 days. 💉💥🧬
Genezen Revolutionizes Vector Production with CSL Licensing
📢 Genezen becomes first CDMO to license CSL's Cytegrity system, helping to alleviate viral vector shortage and improve quality. 🚀👩🔬💊
Gene Therapy Supplier Raises £7M for Breakthrough Technology
💰 Gene therapy supplier MIP Discovery secures £7M in funding to boost commercialization of synthetic affinity reagents in cell and gene therapy. 🧬🔬👥
Revolutionary System Boosts Lentiviral Vector Production
📝 Scaling-up production of lentiviral vectors (LV)-based therapies is a challenge for biomanufacturers. 😎🔬 McGill University researchers have developed a semi-continuous manufacturing system that enhances the quantity and recovery of LVs, reduces instability, and cuts processing time by four-fold. ⏱️💪 The system integrates upstream and downstream bioprocesses, resulting in significant time savings. 💡✨ It operates by rotating membranes between two systems, improving efficiency. 🔄🔝
